NCT01657201View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Systemic Mycotic Infection
Interventions
DRUG

SYP-1018 200mg

SYP-1018 200mg, Intravenous administration

DRUG

Voriconazole 200mg

Voriconazole 200mg, Intravenous administration

Trial Locations (1)

Unknown

Clinical Research Institute, Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT01657201 - Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend) | Biotech Hunter | Biotech Hunter